Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 181 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

 		Chronic Pruritus of Unknown Origin Phase3 Japan
United States 		NCT07700056

A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors

 		Advanced Gastroesophageal Adenocarcinoma, Advanced Breast Cancer, Triple-negative Breast Cancer, Advanced Non-small Cell Lung Cancer Phase1 Japan NCT07801508

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

 		Sjögren's Disease Phase2 Australia
Canada
Israel
United States
View all
 NCT07737743

A 52-week Study of Remibrutinib in IgE-mediated Food Allergy

 		IgE-Mediated Food Allergy, Peanut Allergy, Cow Milk Allergy, Egg Allergy Phase3 United States NCT07768371

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

 		Cutaneous Lichen Planus Phase2 Australia
United States 		NCT07775924

A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment

 		Primary Immune Thrombocytopenia United States NCT07786077

A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

 		Multiple Sclerosis United States NCT07779460

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

 		Asthma Phase3 Poland
South Africa 		NCT05776927

Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)

 		Chronic Spontaneous Urticaria Germany NCT07642557

A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag

 		Immune Thrombocytopenia Switzerland NCT07587723